Phase III trial of vandetanib compared with erlotinib in patients with previously treated advanced non-small-cell lung cancer.
暂无分享,去创建一个
Michael Thomas | S. Thongprasert | P. Sunpaweravong | Chun-Ming Tsai | D. Ferry | F. Barlesi | F. Greco | S. Gogov | R. Natale | G. Goss | P. Langmuir | J. Rowbottom | C. Mulatero | R. Whorf | J. Thompson | C. Tsai